Key result
Elevated plasma levels of MMP-7, MMP-8, and TIMP-1 above cut-offs were associated with overall survival in colorectal cancer patients.
Why the study?
Studies investigating circulating MMPs and TIMPs as cancer biomarkers have yielded confounding results, potentially due to preanalytical issues like using serum instead of plasma.
Are plasma levels of selected MMPs and TIMPs associated with the diagnosis and prognosis of colorectal cancer?
Case-Control (n=216)
No
Are plasma levels of selected MMPs and TIMPs associated with the diagnosis and prognosis of colorectal cancer?
Answers are grounded in this paper and cite their sources.
Plasma MMP-7, MMP-8, and TIMP-1 are potential prognostic biomarkers for colorectal cancer, though they lack diagnostic utility.
Introduction Matrix metalloproteinases (MMPs) are enzymes participating in tumorigenesis and tumor progression through their proteolytic and cell-signaling properties. They are regulated mostly by endogenous tissue inhibitors of metalloproteinases (TIMPs). The expression of both MMPs and TIMPs is often altered in cancers. Many studies investigated their potential as circulating cancer biomarkers, with confounding results, which might be induced by preanalytical issues, particularly by using serum instead of plasma. The study aims to investigate plasma levels of selected MMPs and TIMPs in association with the diagnosis and prognosis of colorectal cancer. Methods The clinico-pathological data of 148 patients operated for colorectal cancer were collected from the medical records system at the University Hospital Pilsen. Sixty-eight age-matched healthy subjects were included as controls. Plasma levels of MMP-2, -7, -8, -9, -10, and TIMP-1, -2, -3, and -4 were assessed with multiplex immunoassays with the technology xMAP. Results MMP-8 and -9 levels were significantly elevated in patients ( P = 0.0002 and 0.0009, respectively), TIMP-2 levels were significantly decreased in colorectal cancer patients ( P = 0.0016). When comparing the early colorectal cancer (stage I and II) with advanced colorectal cancer (stage III and IV), MMP-8 and TIMP-1 were significantly increased in advanced colorectal cancer ( P = 0.0173 and <0.0001, respectively). The area under the curve and the receiver operating characteristic were between 0.680 and 0.530 for all studied biomarkers. In univariate analysis, overall survival was significantly elevated in patients with MMP-7, -8, or TIMP-1, which was higher than cut-offs (hazard ratio = 4.57, 2.03, and 7.64, respectively). Conclusion These findings suggest that plasma MMP-7, MMP-8, and TIMP-1 are potential prognostic biomarkers for colorectal cancer . None of the investigated biomarkers revealed diagnostic potential.
No takes yet. Share an insight, caveat, or question.
Karlíková et al. (2025) conducted a case-control in Colorectal cancer (n=216). Elevated plasma MMP-7, MMP-8, and TIMP-1 vs. Levels below cut-offs / healthy controls was evaluated on Overall survival (HR 4.57, 2.03, and 7.64). Elevated plasma levels of MMP-7, MMP-8, and TIMP-1 above cut-offs were associated with overall survival in colorectal cancer patients.
Synapse has enriched 10 related papers. Consider them for comparative context: